Hyperprocalcitonemia in Patients with Noninfectious SIRS and Pulmonary Dysfunction Associated with Cardiopulmonary Bypass
Authors:
- Thomas VolkTVThomas Volk
- Wolf D. DockeWDWolf D. Docke
- Florian KernFKFlorian Kern
- Dirk TschirnaDTDirk Tschirna
- Karl EgererKEKarl Egerer
- Wolfgang KonertzWKWolfgang Konertz
- Wolfgang J. KoxWKWolfgang J. Kox
- 1 July 1998
- journal article
- research article
- Published by Wolters Kluwer Health in Anesthesiology
- Vol. 89 (1) , 93-104
Abstract
Background: The incidence of noninfectious systemic inflammatory response syndrome (SIRS) associated with coronary artery bypass surgery and the potential role of several inflammatory parameters as early markers of pulmonary dysfunction induced by cardiopulmonary bypass (CPB) were investigated. Methods: Forty patients undergoing elective coronary artery bypass surgery were studied prospectively. Perioperative lung function was monitored using the lung injury score introduced by Murray and colleagues, by measuring venous admixture (Qs/Qt), and, in some cases, by measuring extravascular lung water. Serum concentrations of the inflammatory parameters (procalcitonin, interleukin-6, sL-selectin, leukocyte elastase, neopterin, leukocyte counts, and C-reactive protein) were determined sequentially. The American College of Chest Physicians-Society of Critical Care Medicine classification system was used to diagnose SIRS. Results: According to the entry criteria, SIRS developed in 17 (42%) patients after operation. Nine patients of this group showed signs of acute pulmonary impairment, whereas patients without SIRS had no lung injury. In all patients with acute lung injury, distinct increases in procalcitonin concentrations ranging from 5.1 to 14.3 ng/ml were measured. In patients with SIRS but without acute lung injury and in patients without SIRS, none or only negligible increases in serum concentrations of procalcitonin were seen. Compared with procalcitonin, other inflammatory parameters investigated were less sensitive and less specific to indicate pulmonary dysfunction secondary to CPB. Conclusions: Procalcitonin seems to be an appropriate parameter indicating the early development of severe noninfectious SIRS and for predicting pulmonary dysfunction secondary to CPB.Keywords
This publication has 24 references indexed in Scilit:
- The Systemic Inflammatory Response to Cardiopulmonary BypassAnesthesia & Analgesia, 1997
- Endothelial Cell Injury in Cardiovascular SurgeryThe Annals of Thoracic Surgery, 1996
- Systemic inflammatory response syndrome after cardiac operationsThe Annals of Thoracic Surgery, 1996
- Relationship between pulmonary oxygen consumption, lung inflammation, and calculated venous admixture in patients with acute lung injuryIntensive Care Medicine, 1996
- Hemangioma of the esophagusThe Annals of Thoracic Surgery, 1996
- Circulating Adhesion Molecules in Pediatric Cardiac SurgeryAnesthesia & Analgesia, 1995
- Inflammatory response to cardiopulmonary bypassThe Annals of Thoracic Surgery, 1993
- High serum procalcitonin concentrations in patients with sepsis and infectionThe Lancet, 1993
- Adult respiratory distress syndrome following cardiopulmonary bypass: incidence and predictionAnaesthesia, 1992
- An Expanded Definition of the Adult Respiratory Distress SyndromeAmerican Review of Respiratory Disease, 1988